News

The permit for WeRide’s Robovan W5 marks the company’s second active road testing authorization, following an earlier approval in Guangzhou’s Nansha District in April. This makes WeRide the first and ...
The collaboration will allow Wix merchants to grow their global wholesale capabilities through Alibaba.com, while Alibaba.com ...
Shares of Centene (NYSE: CNC) plunged more than 32% in premarket trading Wednesday after the company pulled its 2025 guidance ...
Investing.com -- Goldman Sachs began coverage of mid‑cap U.S. athleisure names with a cautious stance, arguing that stiffer ...
Wolfe Research downgraded Stellantis (NYSE: STLA) to Underperform in a note Wednesday, citing structural challenges and macroeconomic headwinds that could weigh o ...
Redburn Atlantic downgraded Adobe (NASDAQ: ADBE) shares to Sell from Neutral, flagging mounting risks to its competitive ...
Instil Bio Inc (NASDAQ:TIL) stock surged 10% after the clinical-stage biopharmaceutical company announced the clearance of an Investigational New Drug (IND) application for AXN-2510 by the U.S. Food ...
Archer Aviation Inc. (NYSE: ACHR) stock rose 2% after the company completed its first test flight of the Midnight aircraft in Abu Dhabi, marking a significant ste ...
Investing.com -- Ross Stores Inc rose about 2% to $132.55 in Wednesday’s pre‑market trade after Jefferies upgraded the off‑price retailer to Buy, saying its shares look cheap next to rivals and that ...
Investing.com -- Rivian Automotive (NASDAQ: RIVN) stock fell 0.5% after the electric vehicle maker produced fewer vehicles than expected in the second quarter, despite delivering more vehicles than it ...
Del Monte Foods, a U.S. unit of Singapore-based Del Monte Pacific, has filed for Chapter 11 bankruptcy protection with plans to pursue a sale of its assets. The foods maker said it has reached a ...
BofA Securities upgraded UCB SA to “buy” from “neutral,” raising its price objective to €225 from €210, citing strong commercial momentum for its inflammatory disease drug, Bimzelx.  The analysts ...